These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 3545881

  • 1. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
    Stiff PJ, Koester AR.
    Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM, Yeager AM.
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [Abstract] [Full Text] [Related]

  • 3. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS, Sikic BI, Blume KG, Chao NJ.
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [Abstract] [Full Text] [Related]

  • 4. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM, Gulati SC.
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G, Brashear T, Stone M, Fay J.
    Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
    [Abstract] [Full Text] [Related]

  • 6. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE.
    Stem Cells; 1997 Sep; 15(1):50-5. PubMed ID: 9007222
    [Abstract] [Full Text] [Related]

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 8. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Dec; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P, Pulsoni A, Sandrelli A, Simone F, Amadori S, Meloni G, Mandelli F.
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [Abstract] [Full Text] [Related]

  • 10. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD, Ploemacher RE.
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [Abstract] [Full Text] [Related]

  • 11. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ, Colvin OM, Sensenbrenner LL.
    Cancer Res; 1988 Jun 15; 48(12):3394-7. PubMed ID: 3285994
    [Abstract] [Full Text] [Related]

  • 12. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P.
    Exp Hematol; 1989 Aug 15; 17(7):843-6. PubMed ID: 2753092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec 15; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 15. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).
    Deconinck E, Tamayo E, Hervé P.
    Bone Marrow Transplant; 1990 Jan 15; 5(1):13-8. PubMed ID: 2297586
    [Abstract] [Full Text] [Related]

  • 16. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F, Bernard A, Bueren JA.
    Exp Hematol; 1998 Feb 15; 26(2):100-9. PubMed ID: 9472799
    [Abstract] [Full Text] [Related]

  • 17. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells.
    Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ.
    Nature; 1990 Sep 13; 347(6289):188-9. PubMed ID: 2395470
    [Abstract] [Full Text] [Related]

  • 18. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
    Robinson S, van Os R, Sheridan T, Mauch P.
    Stem Cells; 2000 Sep 13; 18(2):93-101. PubMed ID: 10742381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
    Chiang KY, Haight A, Horan J, Olson E, Gartner A, Hartman D, Youssef S, Worthington-White D.
    Pediatr Transplant; 2007 May 13; 11(3):279-85. PubMed ID: 17430483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.